Nifty

:

23398.10

Sensex

:

74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Login

Nifty
Sensex

:
:

23398.10
74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

Rating :

51/99

BSE: 532612 | NSE: INDOCO

Watchlist

NSE BSE

263.02

11-Sep-2026

Open
High
Low
Previous Close

260
276.98
251.5
254.25

Volume
Traded Value (lacs)
52 Week High
52 Week Low

5002402
1314416876.42
325
162.19

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

2,430.35
431.68
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,433.21
0.08%
2.43

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.55
3.67
0.51

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-1.18
-15.91
-10.31

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

24.38
22.45
-

P:BV (Average)

8 Years
5 Years
3 Years

3.08
3.04
2.57

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.97
19.11
23.76

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 408.97 394.31 3.72% 449.13 347.25 29.34% 400.51 372.98 7.38% 442.12 396.53 11.50%
Expenses 366.76 379.49 -3.35% 386.10 343.79 12.31% 374.61 352.84 6.17% 388.73 343.66 13.11%
EBITDA 42.21 14.82 184.82% 63.03 3.46 1,721.68% 25.90 20.14 28.60% 53.39 52.87 0.98%
EBIDTM 10.32% 3.76% 14.03% 1.00% 6.47% 5.40% 12.08% 13.33%
Other Income 4.47 5.58 -19.89% 10.35 6.50 59.23% 7.17 4.26 68.31% 6.54 4.20 55.71%
Interest 22.75 23.61 -3.64% 22.73 15.98 42.24% 20.15 14.00 43.93% 22.01 14.77 49.02%
Depreciation 28.05 25.20 11.31% 26.71 24.88 7.36% 27.36 24.75 10.55% 27.63 24.92 10.87%
PBT 93.22 -28.41 - 27.62 -30.90 - -20.45 -13.36 - 9.76 17.38 -43.84%
Tax 10.90 -0.34 - 0.27 -4.66 - -0.45 -3.13 - -5.29 4.59 -
PAT 82.32 -28.07 - 27.35 -26.24 - -20.00 -10.23 - 15.05 12.79 17.67%
PATM 20.13% -7.12% 6.09% -7.56% -4.99% -2.74% 3.40% 3.23%
EPS 8.92 -3.04 - 2.96 -2.84 - -2.17 -1.11 - 1.63 1.39 17.27%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 467.50 439.67 6.33% 475.61 390.21 21.89% 445.36 410.55 8.48% 484.67 432.66 12.02%
Expenses 426.48 422.14 1.03% 425.90 390.99 8.93% 413.85 398.52 3.85% 441.62 392.41 12.54%
EBITDA 41.02 17.53 134.00% 49.71 -0.78 - 31.51 12.03 161.93% 43.05 40.25 6.96%
EBIDTM 8.77% 3.99% 10.45% -0.20% 7.08% 2.93% 8.88% 9.30%
Other Income 2.18 1.63 33.74% -0.04 2.02 - 0.98 0.85 15.29% 0.76 1.56 -51.28%
Interest 28.29 26.12 8.31% 45.92 17.98 155.39% 25.64 16.11 59.16% 24.56 17.83 37.75%
Depreciation 34.53 29.70 16.26% 32.49 28.78 12.89% 32.01 28.72 11.46% 32.25 28.82 11.90%
PBT 77.72 -36.66 - -25.00 -45.52 - -31.31 -30.96 - -13.53 -4.84 -
Tax 12.28 -0.31 - -1.32 -4.18 - -1.86 -2.56 - -4.32 5.17 -
PAT 65.44 -36.35 - -23.68 -41.34 - -29.45 -28.40 - -9.21 -10.01 -
PATM 14.00% -8.27% -4.98% -10.59% -6.61% -6.92% -1.90% -2.31%
EPS 7.04 -3.88 - -2.34 -4.38 - -3.23 -2.86 - -0.86 -1.04 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,700.73 1,686.07 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99 967.73 1,038.21 1,072.06 Net Sales Growth 12.55% 11.06% -15.22% 7.45% 8.25% 24.14% 12.14% 14.29% -6.79% -3.16% Cost Of Goods Sold 519.83 500.55 443.68 546.45 521.29 456.75 354.07 330.43 320.17 346.03 359.60 Gross Profit 1,180.90 1,185.52 1,074.50 1,244.35 1,145.40 1,082.97 886.24 775.57 647.56 692.18 712.46 GP Margin 69.43% 70.31% 70.78% 69.49% 68.72% 70.34% 71.45% 70.12% 66.92% 66.67% 66.46% Total Expenditure 1,516.20 1,533.54 1,390.16 1,540.71 1,381.85 1,213.81 1,022.67 985.01 891.03 906.73 917.40 Power & Fuel Cost - 55.44 53.45 55.31 50.61 42.78 36.89 34.75 28.49 26.62 23.12 % Of Sales - 3.29% 3.52% 3.09% 3.04% 2.78% 2.97% 3.14% 2.94% 2.56% 2.16% Employee Cost - 393.63 368.74 350.55 321.15 294.95 272.88 255.32 231.26 220.34 216.05 % Of Sales - 23.35% 24.29% 19.57% 19.27% 19.16% 22.00% 23.09% 23.90% 21.22% 20.15% Manufacturing Exp. - 213.84 193.68 244.20 195.91 184.62 130.30 114.61 106.86 101.47 96.11 % Of Sales - 12.68% 12.76% 13.64% 11.75% 11.99% 10.51% 10.36% 11.04% 9.77% 8.96% General & Admin Exp. - 134.37 137.13 132.67 122.71 107.50 98.28 128.33 110.90 109.03 116.21 % Of Sales - 7.97% 9.03% 7.41% 7.36% 6.98% 7.92% 11.60% 11.46% 10.50% 10.84% Selling & Distn. Exp. - 143.74 148.28 146.97 111.33 83.19 76.02 89.28 62.75 70.53 73.22 % Of Sales - 8.53% 9.77% 8.21% 6.68% 5.40% 6.13% 8.07% 6.48% 6.79% 6.83% Miscellaneous Exp. - 91.97 45.19 64.55 58.84 44.02 54.23 32.31 30.58 32.70 73.22 % Of Sales - 5.45% 2.98% 3.60% 3.53% 2.86% 4.37% 2.92% 3.16% 3.15% 3.09% EBITDA 184.53 152.53 128.03 250.10 284.84 325.91 217.63 120.98 76.70 131.48 154.66 EBITDA Margin 10.85% 9.05% 8.43% 13.97% 17.09% 21.17% 17.55% 10.94% 7.93% 12.66% 14.43% Other Income 28.53 34.26 18.48 17.38 2.62 6.71 9.05 4.79 6.71 8.15 6.10 Interest 87.64 88.50 56.63 37.80 25.27 17.43 22.22 26.25 21.09 23.51 6.16 Depreciation 109.75 106.90 98.25 87.98 70.60 78.95 73.12 70.81 71.56 67.71 63.27 PBT 110.15 -8.59 -8.37 141.70 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 Tax 5.43 -5.82 1.36 36.58 50.23 81.71 38.96 4.46 -6.40 7.23 13.88 Tax Rate 4.93% 50.83% -18.43% 23.87% 26.22% 34.59% 29.66% 15.53% 69.26% 14.93% 15.20% PAT 104.72 -5.63 -8.73 116.64 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 PAT before Minority Interest 104.72 -5.63 -8.73 116.64 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.16% -0.33% -0.58% 6.51% 8.48% 10.04% 7.45% 2.19% -0.29% 3.97% 7.23% PAT Growth 302.36% - - -17.49% -8.52% 67.25% 280.99% - - -46.81% EPS 11.35 -0.61 -0.95 12.64 15.32 16.74 10.01 2.63 -0.31 4.46 8.39

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,873.14 1,845.32 1,664.92 1,817.29 1,668.61 1,540.75 1,241.53 1,106.58 968.45 1,041.94 1,074.77 Net Sales Growth 11.96% 10.84% -8.38% 8.91% 8.30% 24.10% 12.20% 14.26% -7.05% -3.05% Cost Of Goods Sold 564.82 541.74 498.18 559.18 521.29 456.79 354.10 330.43 320.25 347.83 361.27 Gross Profit 1,308.32 1,303.58 1,166.73 1,258.10 1,147.32 1,083.97 887.42 776.15 648.19 694.11 713.49 GP Margin 69.85% 70.64% 70.08% 69.23% 68.76% 70.35% 71.48% 70.14% 66.93% 66.62% 66.39% Total Expenditure 1,707.85 1,708.13 1,565.67 1,580.87 1,382.57 1,214.50 1,023.20 985.74 891.80 910.37 920.27 Power & Fuel Cost - 62.14 59.61 56.00 50.61 42.78 36.89 34.75 28.49 26.62 23.12 % Of Sales - 3.37% 3.58% 3.08% 3.03% 2.78% 2.97% 3.14% 2.94% 2.55% 2.15% Employee Cost - 425.68 394.01 361.93 322.58 296.28 274.02 256.51 231.66 220.91 216.67 % Of Sales - 23.07% 23.67% 19.92% 19.33% 19.23% 22.07% 23.18% 23.92% 21.20% 20.16% Manufacturing Exp. - 239.65 214.28 247.42 195.91 184.62 130.32 114.63 107.07 101.94 96.38 % Of Sales - 12.99% 12.87% 13.61% 11.74% 11.98% 10.50% 10.36% 11.06% 9.78% 8.97% General & Admin Exp. - 151.16 152.06 137.54 121.88 106.75 97.57 127.76 110.92 110.04 116.40 % Of Sales - 8.19% 9.13% 7.57% 7.30% 6.93% 7.86% 11.55% 11.45% 10.56% 10.83% Selling & Distn. Exp. - 179.34 189.69 149.45 111.33 83.19 76.02 89.28 62.75 70.53 73.22 % Of Sales - 9.72% 11.39% 8.22% 6.67% 5.40% 6.12% 8.07% 6.48% 6.77% 6.81% Miscellaneous Exp. - 108.42 57.83 69.34 58.95 44.10 54.28 32.38 30.66 32.49 73.22 % Of Sales - 5.88% 3.47% 3.82% 3.53% 2.86% 4.37% 2.93% 3.17% 3.12% 3.09% EBITDA 165.29 137.19 99.25 236.42 286.04 326.25 218.33 120.84 76.65 131.57 154.50 EBITDA Margin 8.82% 7.43% 5.96% 13.01% 17.14% 21.17% 17.59% 10.92% 7.91% 12.63% 14.38% Other Income 3.88 7.96 5.45 18.72 2.63 3.42 9.06 4.80 6.70 8.05 5.93 Interest 124.41 122.25 66.23 39.01 25.27 14.14 22.26 26.25 21.09 23.51 6.21 Depreciation 131.28 126.45 113.84 91.87 70.61 78.96 73.13 70.82 71.57 67.71 63.28 PBT 7.88 -103.55 -75.36 124.27 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 Tax 4.78 -7.81 3.58 38.79 50.54 81.77 38.95 4.45 -6.41 7.24 13.87 Tax Rate 60.66% 7.33% -4.81% 28.56% 26.22% 34.56% 29.51% 15.58% 68.85% 14.96% 15.25% PAT 3.10 -95.13 -73.74 98.46 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 PAT before Minority Interest 5.63 -98.68 -77.95 97.00 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 Minority Interest 2.53 3.55 4.21 1.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 0.17% -5.16% -4.43% 5.42% 8.53% 10.05% 7.49% 2.18% -0.30% 3.95% 7.17% PAT Growth 102.67% - - -30.78% -8.11% 66.36% 285.78% - - -46.59% EPS 0.34 -10.31 -7.99 10.67 15.41 16.77 10.08 2.61 -0.31 4.46 8.35

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 1,099.19 1,103.36 1,126.62 1,027.02 904.30 768.93 680.16 661.08 675.56 651.88 Share Capital 18.46 18.45 18.44 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 1,074.31 1,079.17 1,104.64 1,007.93 885.87 750.50 661.73 642.65 657.13 633.45 Non-Current Liabilities 390.44 402.79 271.74 205.41 156.57 158.29 100.91 116.34 125.27 146.97 Secured Loans 301.61 336.89 203.60 143.50 95.88 96.94 96.93 128.66 123.28 132.31 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 34.68 34.88 33.47 33.33 31.64 66.20 27.08 15.91 23.74 30.87 Current Liabilities 884.69 695.01 595.03 483.21 519.93 408.54 459.17 445.33 416.89 390.37 Trade Payables 260.55 147.38 118.97 126.45 135.32 115.02 166.29 170.70 149.44 164.17 Other Current Liabilities 252.79 169.16 144.66 131.88 139.46 129.33 135.35 117.02 119.32 72.07 Short Term Borrowings 315.72 333.40 250.35 119.45 103.73 117.31 105.98 113.39 109.93 118.36 Short Term Provisions 55.63 45.07 81.05 105.43 141.41 46.88 51.55 44.21 38.19 35.77 Total Liabilities 2,374.32 2,201.16 1,993.39 1,715.64 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 Net Block 851.46 754.38 732.34 661.46 554.98 569.91 589.62 467.52 488.73 439.75 Gross Block 1,851.25 1,665.59 1,554.80 1,406.09 1,236.03 1,177.68 1,126.60 934.50 884.96 769.49 Accumulated Depreciation 999.79 911.21 822.46 744.63 681.05 607.76 536.99 466.98 396.23 329.74 Non Current Assets 1,251.39 1,262.28 1,060.39 847.21 714.79 713.81 678.48 686.25 680.57 619.04 Capital Work in Progress 85.21 225.78 114.44 112.57 121.53 68.10 50.70 185.43 135.56 90.63 Non Current Investment 159.75 51.96 51.96 18.90 2.46 2.45 2.45 2.44 2.61 2.82 Long Term Loans & Adv. 146.82 223.85 154.87 52.03 33.68 71.29 34.02 29.30 40.73 71.69 Other Non Current Assets 8.15 6.30 6.78 2.25 2.13 2.05 1.68 1.56 12.94 14.15 Current Assets 1,099.52 938.88 932.99 868.44 866.01 621.95 561.76 536.50 537.15 570.11 Current Investments 0.00 0.00 7.24 1.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 321.83 362.86 310.42 325.99 310.52 237.81 208.24 183.37 193.23 185.04 Sundry Debtors 541.20 374.05 408.02 350.82 297.00 233.58 209.18 194.47 207.83 215.73 Cash & Bank 20.00 12.03 16.94 12.40 19.21 14.05 37.65 36.18 11.81 62.40 Other Current Assets 216.48 72.90 59.63 20.17 239.29 136.50 106.70 122.48 124.28 106.95 Short Term Loans & Adv. 141.60 117.02 130.73 158.06 204.70 124.61 97.59 106.94 117.83 89.38 Net Current Assets 214.83 243.87 337.96 385.23 346.08 213.41 102.59 91.17 120.27 179.74 Total Assets 2,350.91 2,201.16 1,993.38 1,715.65 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.15

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 939.28 1,022.00 1,109.90 1,028.25 904.64 768.99 679.57 660.62 674.98 651.34 Share Capital 18.46 18.45 18.44 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 914.40 997.81 1,087.93 1,009.16 886.21 750.56 661.14 642.19 656.55 632.91 Non-Current Liabilities 608.61 603.54 421.90 205.44 156.60 158.36 101.00 116.42 125.34 147.04 Secured Loans 474.52 533.20 351.73 143.50 95.88 96.94 96.93 128.66 123.28 132.31 Unsecured Loans 41.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 35.65 35.82 33.68 33.40 31.74 66.35 27.14 15.95 23.77 30.91 Current Liabilities 1,061.86 808.47 645.50 480.79 518.16 406.92 458.99 445.50 417.36 390.39 Trade Payables 308.52 208.13 153.64 123.46 133.29 113.23 165.60 170.72 149.55 164.03 Other Current Liabilities 323.12 192.71 149.80 132.06 139.61 129.48 135.81 117.13 119.66 72.16 Short Term Borrowings 374.03 362.01 260.52 119.45 103.73 117.31 105.98 113.39 109.93 118.36 Short Term Provisions 56.20 45.62 81.53 105.82 141.53 46.91 51.59 44.26 38.22 35.84 Total Liabilities 2,602.58 2,430.39 2,177.90 1,714.48 1,579.40 1,334.27 1,239.56 1,222.54 1,217.68 1,188.77 Net Block 1,193.11 996.88 954.29 678.25 555.10 569.94 589.74 467.65 488.86 439.89 Gross Block 2,231.78 1,927.63 1,780.68 1,422.93 1,236.19 1,177.74 1,126.76 934.65 885.11 769.65 Accumulated Depreciation 1,038.67 930.74 826.39 744.68 681.09 607.80 537.02 467.00 396.25 329.75 Non Current Assets 1,399.91 1,428.57 1,190.06 844.63 712.47 711.75 676.45 684.49 678.73 616.72 Capital Work in Progress 90.01 320.54 124.81 113.60 121.53 68.19 50.70 185.43 135.56 90.63 Non Current Investment 1.46 1.46 1.46 1.46 0.02 0.02 0.02 0.02 0.02 0.02 Long Term Loans & Adv. 101.69 102.75 102.45 49.06 33.69 71.54 34.30 29.83 41.35 72.02 Other Non Current Assets 13.64 6.93 7.04 2.26 2.13 2.05 1.68 1.56 12.94 14.15 Current Assets 1,179.26 1,001.82 987.84 869.85 866.92 622.53 563.10 538.05 538.96 571.98 Current Investments 0.00 0.00 7.24 1.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 405.21 419.35 353.06 325.99 310.52 237.85 208.32 183.45 193.38 186.94 Sundry Debtors 489.17 352.41 406.20 350.94 297.25 233.82 210.14 195.84 209.51 215.68 Cash & Bank 32.99 17.08 24.32 13.34 19.77 14.34 37.93 36.26 11.90 62.59 Other Current Assets 251.89 45.50 42.23 20.18 239.39 136.52 106.71 122.51 124.17 106.78 Short Term Loans & Adv. 205.04 167.48 154.78 158.41 204.80 124.62 97.60 106.96 117.71 89.21 Net Current Assets 117.40 193.35 342.34 389.06 348.77 215.61 104.12 92.55 121.60 181.60 Total Assets 2,579.17 2,430.39 2,177.90 1,714.48 1,579.39 1,334.28 1,239.55 1,222.54 1,217.69 1,188.70

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 226.35 107.36 176.78 178.79 173.55 82.17 122.66 132.13 122.76 87.81 PBT -8.59 -8.37 141.70 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 Adjustment 178.18 147.22 130.08 120.88 87.12 109.71 99.51 89.34 97.82 64.31 Changes in Working Capital 65.55 -15.89 -77.42 -72.29 -108.81 -139.14 -1.65 55.66 -13.59 -44.07 Cash after chg. in Working capital 235.14 122.96 194.36 240.18 214.54 101.92 126.57 135.75 132.65 111.57 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -5.93 -16.60 -29.10 -61.38 -40.99 -19.75 -3.92 -3.62 -9.89 -23.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -2.86 0.99 11.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -87.38 -276.39 -301.70 -208.51 -121.41 -66.70 -55.95 -103.76 -135.43 -170.54 Net Fixed Assets -45.09 -222.13 -150.58 -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 Net Investments -107.79 7.24 -39.30 -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 Others 65.50 -61.50 -111.82 -29.97 -9.62 1.78 1.43 -4.52 24.76 -22.27 Cash from Financing Activity -133.09 168.62 122.40 22.81 -44.37 -29.83 -63.95 -16.14 -38.77 132.40 Net Cash Inflow / Outflow 5.87 -0.41 -2.52 -6.91 7.77 -14.35 2.76 12.23 -51.44 49.67 Opening Cash & Equivalents 7.06 7.47 9.99 16.90 9.13 23.48 20.72 8.48 59.92 10.25 Closing Cash & Equivalent 12.94 7.06 7.47 9.99 16.90 9.13 23.48 20.72 8.48 59.92

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 192.23 94.94 155.39 178.83 173.83 82.22 122.85 132.11 122.72 88.64 PBT -103.55 -75.36 124.27 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 Adjustment 249.98 183.64 137.55 120.88 87.12 109.76 99.51 89.35 97.67 64.60 Changes in Working Capital 54.91 2.79 -88.47 -73.19 -108.79 -139.81 -1.49 55.62 -13.23 -43.25 Cash after chg. in Working capital 201.34 111.07 173.35 240.48 214.91 101.94 126.60 135.66 132.83 112.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -6.17 -17.12 -29.49 -61.65 -41.08 -19.72 -3.75 -3.55 -10.12 -23.65 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -2.94 0.99 11.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -101.61 -339.11 -432.52 -208.17 -121.41 -66.69 -55.93 -103.76 -135.43 -170.55 Net Fixed Assets -45.09 -222.13 -150.58 -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 Net Investments -107.79 7.24 -39.30 -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 Others 51.27 -124.22 -242.64 -29.63 -9.62 1.79 1.45 -4.52 24.76 -22.28 Cash from Financing Activity -76.79 241.42 280.43 22.80 -44.37 -29.87 -63.95 -16.14 -38.77 131.57 Net Cash Inflow / Outflow 13.82 -2.75 3.31 -6.54 8.05 -14.34 2.97 12.22 -51.48 49.66 Opening Cash & Equivalents 12.11 14.86 10.92 17.47 9.42 23.76 20.80 8.58 60.06 10.40 Closing Cash & Equivalent 25.93 12.11 14.86 10.92 17.47 9.42 23.76 20.80 8.58 60.06

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 118.39 118.99 121.83 111.38 98.13 83.44 73.81 71.74 73.31 70.74 ROA -0.25% -0.42% 6.29% 8.58% 10.60% 7.17% 1.97% -0.23% 3.42% 7.26% ROE -0.51% -0.79% 10.85% 14.64% 18.47% 12.75% 3.62% -0.43% 6.21% 12.61% ROCE 4.23% 2.84% 12.89% 17.42% 23.31% 15.59% 5.79% 1.24% 7.61% 11.84% Fixed Asset Turnover 0.96 0.94 1.21 1.26 1.28 1.08 1.07 1.06 1.26 1.55 Receivable days 99.07 94.01 77.33 70.94 62.89 65.15 66.60 75.87 74.21 67.30 Inventory Days 74.11 80.93 64.86 69.70 64.99 65.63 64.62 71.02 66.28 58.30 Payable days 148.73 109.56 81.96 91.64 100.02 145.00 68.05 71.94 66.81 61.95 Cash Conversion Cycle 24.45 65.39 60.23 48.99 27.86 -14.22 63.17 74.95 73.68 63.66 Total Debt/Equity 0.65 0.67 0.44 0.31 0.27 0.34 0.38 0.45 0.42 0.43 Interest Cover 0.87 0.87 5.05 8.58 14.55 6.91 2.09 0.56 3.06 15.83

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 101.06 110.17 120.02 111.51 98.17 83.45 73.75 71.69 73.25 70.68 ROA -3.92% -3.38% 4.98% 8.64% 10.63% 7.23% 1.96% -0.24% 3.42% 7.22% ROE -10.13% -7.34% 9.09% 14.72% 18.50% 12.85% 3.60% -0.43% 6.21% 12.55% ROCE 0.79% -0.43% 11.25% 17.50% 23.03% 15.67% 5.78% 1.23% 7.62% 11.80% Fixed Asset Turnover 0.89 0.90 1.13 1.25 1.28 1.08 1.07 1.06 1.26 1.55 Receivable days 83.23 83.16 76.04 70.89 62.90 65.26 66.96 76.39 74.23 67.31 Inventory Days 81.55 84.67 68.19 69.62 64.95 65.58 64.61 71.01 66.40 58.84 Payable days 174.05 132.53 90.44 89.88 98.49 143.70 67.82 71.91 66.57 61.79 Cash Conversion Cycle -9.27 35.30 53.79 50.63 29.37 -12.86 63.74 75.49 74.06 64.37 Total Debt/Equity 1.11 0.96 0.59 0.31 0.27 0.34 0.39 0.45 0.42 0.43 Interest Cover 0.13 -0.12 4.48 8.63 17.73 6.93 2.09 0.56 3.06 15.64

Top Investors:

nippon life india trustee ltd a/c nippon india small cap fund

quant mutual fund quant small cap fund

dsp healthcare fund

icici prudential pharma healthcare and diaganostics (p.h.d.) fund

hdfc value fund

mangeshi investment private limited

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA completes inspection at Indoco Remedies’ Goa manufacturing facility
7th Sep 2026, 11:37 AM

On conclusion of the inspection, the company received 7 observations in Form 483
Read More
Indoco Remedies executes Deed of Conveyance to sell land in Mumbai
28th Aug 2026, 14:20 PM

The total consideration agreed for sale of land is Rs 64 crore
Read More
Indoco Remedies - Quarterly Results
29th Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback